Guerbet Vendor's profile
Guerbet to double its turnover with the acquisition of Mallinckrodt’s contrast media and delivery systems business Guerbet (FR0000032526 GBT) announced today that it has entered into a definitive agreement under which it will acquire Mallinckrodt’s contrast media and delivery systems busines...
Guerbet signs an agreement with Fuji Pharma to market its range of contrast media in Japan Guerbet (GBT) announces an agreement with Fuji Pharma Co., Ltd, a leading provider of contrast media to distribute and promote its range of contrast media for MRI, X-Ray imaging and interventional radi...
Guerbet reaffirms commitment to interventional radiology at CIRSE 2015
星期一, 2015年 九月 21日
Guerbet reaffirms commitment to interventional radiology at CIRSE 2015 Guerbet has announced its participation to the 30th European Cardiovascular and Interventional Radiology congress (CIRSE Cardiovascular and Interventional Radiological Society of Europe) being held in Lisbon, Portugal fro...
2015 half-year results
星期二, 2015年 九月 29日
2015 half-year results › Current operating income: €30.1 M, an increase of more than 52%› Net financial debt down 36% to €53 M Growth in business activity on the four product segments Strong earnings growth and increased margins Launch of the process of integrating Mallinckrodt’s...
Guerbet signs agreement with Kyuan for promotion & distribution of Lipiodol® Ultra-Fluid in ChinaGuerbet (GBT) announced today the signing of an agreement with Beijing Kyuan Pharmaceutical Co., Ltd., one of the major pharmaceutical drugs distributors & importers in the Chinese market...
To feature here : Get in touch
Ziehm Vision RFD Hybrid Edition: Mobility and flexibility – the difference in an emergency
Olea Medical® literature meta-analysis on CTP thresholds in acute stroke
Agfa HealthCare Special Report Dose Management: because life is precious.
Olea Medical® case report on early & late MR diffusion follow-up of a stroke using CT perfusion.